Spermosens AB (STU:9R5) ROCE % : -38.19% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Spermosens AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Spermosens AB's annualized ROCE % for the quarter that ended in Dec. 2024 was -38.19%.

Spermosens AB ROCE % Historical Data

The historical data trend for Spermosens AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spermosens AB ROCE % Chart

Spermosens AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

-62.91

-44.01

-116.41

-108.18

-45.13

Spermosens AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial														-22.37	-84.56	-46.02	-36.85	-38.19

Spermosens AB ROCE % Calculation

Spermosens AB's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-0.797	/	( ( (2.334 - 1.179)	+	(2.699 - 0.322) )	/ 2 )
	=	-0.797	/	( (1.155	+	2.377)	/ 2 )
	=	-0.797	/	1.766
	=	-45.13 %

Spermosens AB's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	-0.824	/	( ( (2.202 - 0.264)	+	(2.699 - 0.322) )	/ 2 )
	=	-0.824	/	( ( 1.938	+	2.377 )	/ 2 )
	=	-0.824	/	2.1575
	=	-38.19 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Spermosens AB (STU:9R5) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Spermosens AB ROCE % Related Terms

Thank you for viewing the detailed overview of Spermosens AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Spermosens AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spermosens AB (STU:9R5) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

SPERM:Sweden

Address

Scheeletorget 1, Medicon Village, Lund, SWE, 223 81

Website

https://www.spermosens.com

Spermosens AB is developing a revolutionary platform technology for diagnosing male-factor infertility and directing to the right infertility treatment. It is a developer of medical device products for male infertility, individualizing In Vitro Fertilization (IVF) diagnostics and treatment creating a new standard for faster and safer IVF treatments.

Spermosens AB Headlines

No Headlines